Synthesis of an optically active, bicyclic 2-pyridone dipeptide mimeticDRAGOVICH, Peter S; RU ZHOU; PRINS, Thomas J et al.Journal of organic chemistry. 2002, Vol 67, Num 3, pp 741-746, issn 0022-3263Article

Efficient near-infrared quantum cutting in Yb³⁺ doped CaNb₂O₆ phosphor based on energy transferRU ZHOU; XIANTAO WEI; SHAN HUANG et al.Journal of alloys and compounds. 2012, Vol 537, pp 123-126, issn 0925-8388, 4 p.Article

Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection : Advances in Nutritional PharmacologyRU ZHOU; FUKUI, Masayuki; HYE JOUNG CHOI et al.British journal of pharmacology. 2009, Vol 158, Num 2, pp 462-474, issn 0007-1188, 13 p.Article

Current situation on the Holocene chronostratigraphical research in China = Situation actuelle de la recherche sur la chronostratigraphie de l'Holocène en ChineDONG-SHENG LUI; TING-RU ZHOU; CHENG-HUI CHEN et al.1982, Vol 16, pp 21-23, issn 0345-0074Article

Influence of Cationic Precursors on CdS Quantum-Dot-Sensitized Solar Cell Prepared by Successive Ionic Layer Adsorption and ReactionRU ZHOU; QIFENG ZHANG; JIANJUN TIAN et al.Journal of physical chemistry. C. 2013, Vol 117, Num 51, pp 26948-26956, issn 1932-7447, 9 p.Article

Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in ratRU ZHOU; QINGBIN XU; PING ZHENG et al.European journal of pharmacology. 2008, Vol 586, Num 1-3, pp 244-250, issn 0014-2999, 7 p.Article

IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responsesWAI PO CHONG; HORAI, Reiko; MATTAPALLIL, Mary J et al.Journal of autoimmunity (Print). 2014, Vol 50, pp 12-22, issn 0896-8411, 11 p.Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimeticsDRAGOVICH, Peter S; PRINS, Thomas J; LEE, Caroline A et al.Journal of medicinal chemistry (Print). 2003, Vol 46, Num 21, pp 4572-4585, issn 0022-2623, 14 p.Article

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsDRAGOVICH, P. S; RU ZHOU; MEADOR, J. W et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 1, pp 45-48, issn 0960-894XArticle

Crystal Growth of Hen Egg-White Lysozyme (HEWL) under Various Gravity ConditionsWEICHUN PAN; JIN XU; TSUKAMOTO, Katsuo et al.Journal of crystal growth. 2013, Vol 377, pp 43-50, issn 0022-0248, 8 p.Article

(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivoRU ZHOU; FAN ZHANG; LI, Yuan-Chao et al.International immunopharmacology. 2005, Vol 5, Num 13-14, pp 1895-1903, issn 1567-5769, 9 p.Article

Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cellsWEI TANG; YANG YANG; FAN ZHANG et al.International immunopharmacology. 2005, Vol 5, Num 13-14, pp 1904-1913, issn 1567-5769, 10 p.Article

Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitorsWEBBER, Stephen E; MARAKOVITS, Joseph T; MORAN, Terry et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 20, pp 2683-2686, issn 0960-894XArticle

(5R)-5-hydroxytriptolide inhibits the immune response of human peripheral blood mononuclear cellsRU ZHOU; WEI TANG; HE, Pei-Lan et al.International immunopharmacology (Print). 2009, Vol 9, Num 1, pp 63-69, issn 1567-5769, 7 p.Article

Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantationWEI TANG; RU ZHOU; YANG YANG et al.Transplantation. 2006, Vol 81, Num 6, pp 927-933, issn 0041-1337, 7 p.Article

Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitisRU ZHOU; WEI TANG; REN, Yong-Xin et al.European journal of pharmacology. 2006, Vol 537, Num 1-3, pp 181-189, issn 0014-2999, 9 p.Article

Involvement of human liver cytochrome P450 3A in vinblastine metabolism : drug interactionsXIN-RU ZHOU-PAN; SEREE, E; XIAO-JIAN ZHOU et al.Cancer research (Baltimore). 1993, Vol 53, Num 21, pp 5121-5126, issn 0008-5472Article

Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation : metabolic drug interactionsXIAO-JIAN ZHOU; XIN-RU ZHOU-PAN; GAUTHIER, T et al.Biochemical pharmacology. 1993, Vol 45, Num 4, pp 853-861, issn 0006-2952Article

Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocyclePFEFFERKORN, Jeffrey A; JIHONG LOU; LITCHFIELD, John et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 12, pp 3247-3252, issn 0960-894X, 6 p.Article

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimeticsDRAGOVICH, Peter S; PRINS, Thomas J; MATTHEWS, David A et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 8, pp 1607-1623, issn 0022-2623Article

Identification of novel pyrrolopyrazoles as protein kinase C β II inhibitorsHUI LI; YUFENG HONG; MINGYING HE et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 1, pp 584-587, issn 0960-894X, 4 p.Article

Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing miceRU ZHOU; HE, Pei-Lan; REN, Yong-Xin et al.Cancer science. 2007, Vol 98, Num 6, pp 882-889, issn 1347-9032, 8 p.Article

Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acidsDRAGOVICH, P. S; WEBBER, S. E; BROWN, E. L et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 15, pp 2189-2194, issn 0960-894XArticle

Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivoWANG, Jun-Xia; WEI TANG; HE, Pei-Lan et al.European journal of pharmacology. 2007, Vol 564, Num 1-3, pp 211-218, issn 0014-2999, 8 p.Article

Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitorsHUI LI; TATLOCK, John; PARGE, Hans et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 18, pp 4834-4838, issn 0960-894X, 5 p.Article